Erratum: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092)

Jia Wang; Peng Cheng; Marat S. Pavlyukov; Hai Yu; Zhuo Zhang; Sung Hak Kim; Mutsuko Minata; Ahmed Mohyeldin; Wanfu Xie; Dongquan Chen; Violaine Goidts; Brendan Frett; Wenhao Hu; Hongyu Li; Yong Jae Shin; Yeri Lee; Do Hyun Nam; Harley I. Kornblum; Maode Wang; Ichiro Nakano

doi:10.1172/JCI144618

Erratum: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092)

Jia Wang, Peng Cheng, Marat S. Pavlyukov, Hai Yu, Zhuo Zhang, Sung Hak Kim, Mutsuko Minata, Ahmed Mohyeldin, Wanfu Xie, Dongquan Chen, Violaine Goidts, Brendan Frett, Wenhao Hu, Hongyu Li, Yong Jae Shin, Yeri Lee, Do Hyun Nam, Harley I. Kornblum, Maode Wang, Ichiro Nakano

Pharmacology and Toxicology

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Abstract

At the request of the corresponding author, the JCI is retracting this article. Several concerns were raised regarding the Western blot data in Figures 1J, 2A, 3A, and 4D and Supplemental Figures 3A, 4C, and 6A. After an extensive internal review, it became apparent that errors were introduced during the preparation of the revised figures. Due to loss of confidence in the published figures, the corresponding author requested retraction. No issues have been raised with regard to any of the other data in the paper.

Original language	English (US)
Pages (from-to)	6187
Number of pages	1
Journal	Journal of Clinical Investigation
Volume	130
Issue number	11
DOIs	https://doi.org/10.1172/JCI144618
State	Published - Nov 2 2020

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1172/JCI144618

Fingerprint

Dive into the research topics of 'Erratum: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092)'. Together they form a unique fingerprint.

Cite this

Wang, J., Cheng, P., Pavlyukov, M. S., Yu, H., Zhang, Z., Kim, S. H., Minata, M., Mohyeldin, A., Xie, W., Chen, D., Goidts, V., Frett, B., Hu, W., Li, H., Shin, Y. J., Lee, Y., Nam, D. H., Kornblum, H. I., Wang, M., & Nakano, I. (2020). Erratum: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092). Journal of Clinical Investigation, 130(11), 6187. https://doi.org/10.1172/JCI144618

Erratum : Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092). / Wang, Jia; Cheng, Peng; Pavlyukov, Marat S. et al.

In: Journal of Clinical Investigation, Vol. 130, No. 11, 02.11.2020, p. 6187.

Research output: Contribution to journal › Comment/debate › peer-review

Wang, J, Cheng, P, Pavlyukov, MS, Yu, H, Zhang, Z, Kim, SH, Minata, M, Mohyeldin, A, Xie, W, Chen, D, Goidts, V, Frett, B, Hu, W, Li, H, Shin, YJ, Lee, Y, Nam, DH, Kornblum, HI, Wang, M & Nakano, I 2020, 'Erratum: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092)', Journal of Clinical Investigation, vol. 130, no. 11, pp. 6187. https://doi.org/10.1172/JCI144618

@article{5ef2e5c8edb742caa93e61b5e44f9f7d,

title = "Erratum: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092)",

abstract = "At the request of the corresponding author, the JCI is retracting this article. Several concerns were raised regarding the Western blot data in Figures 1J, 2A, 3A, and 4D and Supplemental Figures 3A, 4C, and 6A. After an extensive internal review, it became apparent that errors were introduced during the preparation of the revised figures. Due to loss of confidence in the published figures, the corresponding author requested retraction. No issues have been raised with regard to any of the other data in the paper.",

author = "Jia Wang and Peng Cheng and Pavlyukov, {Marat S.} and Hai Yu and Zhuo Zhang and Kim, {Sung Hak} and Mutsuko Minata and Ahmed Mohyeldin and Wanfu Xie and Dongquan Chen and Violaine Goidts and Brendan Frett and Wenhao Hu and Hongyu Li and Shin, {Yong Jae} and Yeri Lee and Nam, {Do Hyun} and Kornblum, {Harley I.} and Maode Wang and Ichiro Nakano",

year = "2020",

month = nov,

day = "2",

doi = "10.1172/JCI144618",

language = "English (US)",

volume = "130",

pages = "6187",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "The American Society for Clinical Investigation",

number = "11",

}

TY - JOUR

T1 - Erratum

T2 - Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092)

AU - Wang, Jia

AU - Cheng, Peng

AU - Pavlyukov, Marat S.

AU - Yu, Hai

AU - Zhang, Zhuo

AU - Kim, Sung Hak

AU - Minata, Mutsuko

AU - Mohyeldin, Ahmed

AU - Xie, Wanfu

AU - Chen, Dongquan

AU - Goidts, Violaine

AU - Frett, Brendan

AU - Hu, Wenhao

AU - Li, Hongyu

AU - Shin, Yong Jae

AU - Lee, Yeri

AU - Nam, Do Hyun

AU - Kornblum, Harley I.

AU - Wang, Maode

AU - Nakano, Ichiro

PY - 2020/11/2

Y1 - 2020/11/2

N2 - At the request of the corresponding author, the JCI is retracting this article. Several concerns were raised regarding the Western blot data in Figures 1J, 2A, 3A, and 4D and Supplemental Figures 3A, 4C, and 6A. After an extensive internal review, it became apparent that errors were introduced during the preparation of the revised figures. Due to loss of confidence in the published figures, the corresponding author requested retraction. No issues have been raised with regard to any of the other data in the paper.

AB - At the request of the corresponding author, the JCI is retracting this article. Several concerns were raised regarding the Western blot data in Figures 1J, 2A, 3A, and 4D and Supplemental Figures 3A, 4C, and 6A. After an extensive internal review, it became apparent that errors were introduced during the preparation of the revised figures. Due to loss of confidence in the published figures, the corresponding author requested retraction. No issues have been raised with regard to any of the other data in the paper.

UR - http://www.scopus.com/inward/record.url?scp=85095460770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095460770&partnerID=8YFLogxK

U2 - 10.1172/JCI144618

DO - 10.1172/JCI144618

M3 - Comment/debate

C2 - 33044225

AN - SCOPUS:85095460770

SN - 0021-9738

VL - 130

SP - 6187

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 11

ER -

Erratum: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Journal of Clinical Investigation (2017) 127:8 (3075-3089) DOI: 10.1172/JCI89092)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this